Most of us understand that our mental state affects how we feel day to day. But a landmark study published in Nature Medicine in January 2026 has taken that understanding to a new level — demonstrating, for the first time in humans, that deliberately activating a specific part of the brain can measurably strengthen the immune system's response to vaccination.
The research, led by Professor Talma Hendler, a neuroscientist and psychiatrist at Tel Aviv University, offers compelling evidence that the mind-body connection is not just a comforting idea — it is a biological reality with measurable, clinical outcomes.
What the Study Found
Researchers recruited healthy volunteers and trained them over four sessions to boost activity in a region of the brain called the ventral tegmental area (VTA) — a core hub of the brain's reward system. Participants used different mental strategies and received real-time feedback on how well they were doing, with scores rising as brain activity increased.
After completing the training, participants received a hepatitis B vaccine. Blood samples taken at two and four weeks post-vaccination were analysed for antibody levels.
The results were striking: participants who successfully activated their VTA — primarily through positive expectations and imagining good outcomes — produced significantly more antibodies against hepatitis B than those who did not. In short, what they were thinking directly influenced how powerfully their immune system responded.
"It's the first demonstration in humans, in what seems to be a causal manner, that if you learn how to recruit your reward system in the brain, the effectiveness of immunisation increases," said Professor Hendler.
Why This Matters
This research is significant for several reasons. First, it confirms the causal link — not just a correlation — between brain state and immune response. Previous animal studies had hinted at this, and the placebo effect had suggested something similar in humans, but this is the clearest evidence yet that conscious mental activity can shape measurable immune outcomes.
Second, it points to the ventral tegmental area specifically. The VTA is heavily involved in dopamine release, motivation, anticipation, and reward. It is the same system that responds to things we look forward to, things that bring us pleasure, and — crucially — states of calm, positive expectation. Practices that naturally engage this system include mindfulness, meditation, and guided therapeutic states.
Third, this opens the door to accessible, non-pharmacological approaches to immune health. Rather than requiring drugs or expensive interventions, participants simply learned to think differently — with measurable biological results.
The Connection to Hypnotherapy
This is where hypnotherapy becomes particularly relevant. Clinical hypnotherapy works by guiding a person into a focused, relaxed state of heightened inner attention — a state in which positive suggestions, expectation shifts, and mental imagery are deeply absorbed by the subconscious mind.
What the Tel Aviv study identifies as the key mechanism — activating the brain's reward system through positive expectation and imagery — is precisely what happens during a well-structured hypnotherapy session. The suggestions woven into the hypnotic state are designed to generate feelings of safety, optimism, and positive anticipation. These are not passive thoughts; they are guided, reinforced, and practised.
Hypnotherapy has long been associated with the reduction of stress hormones like cortisol. Chronic stress suppresses immune function — lowering white blood cell counts, impairing the body's ability to fight infection, and reducing the effectiveness of vaccines. By reducing stress and replacing anxious mental patterns with calm, positive states, hypnotherapy may be supporting immune health through exactly the mechanism this study identifies.
While the research did not study hypnotherapy directly, the overlap is clear: both involve guiding the mind into a focused state of positive expectation, and this study now shows that doing so has measurable, causal effects on the immune system.
What This Means for Everyday Wellbeing
The implications for general wellbeing are significant. If the mental strategies you practise — the quality of your thinking, your relationship with expectation, your capacity for optimism — can influence how your immune system performs, then investing in your mental health is also investing in your physical health.
This is not a fringe idea. The field of psychoneuroimmunology — which studies the relationship between the mind, the nervous system, and immune function — has been building this case for decades. The Tel Aviv study provides one of the clearest human demonstrations yet.
The researchers are clear that this does not mean positive thinking alone can cure disease. Larger trials are needed to establish firm clinical protocols. But as a proof of concept — that intentional mental practice can shift immune biology in a meaningful way — the findings are genuinely groundbreaking.
Want to put your mind's healing potential to work?
Clear Minds guides you into the kind of calm, focused, positive mental state that this research suggests may genuinely support your body's defences. Explore our hypnotherapy sessions — starting with a free 7-day trial — and experience what intentional positive thinking feels like from the inside.
Try hypnotherapy free for 7 daysNo payment today · Full access from day one · Cancel anytime
The Takeaway
A 2026 study published in Nature Medicine has provided the first causal evidence in humans that activating the brain's reward system — through positive expectation and mental imagery — increases antibody production after vaccination. The mechanism closely mirrors what happens during hypnotherapy, where guided positive states are the central tool. While research is ongoing, the finding reinforces what practitioners have long suspected: the way you train your mind has real, measurable consequences for your body.
Source: Hendler et al., Nature Medicine, January 2026. As reported by The Guardian, 19 January 2026.
